Payment overview · 2025
General Payments
$215.05
9 reported records · 5 companies
Healthcare provider profile · identity verified
Mitchell Wicker, MD
Allopathic & Osteopathic Physicians|Internal Medicine · HAZARD, KY · NPI 1730182841
Verified facts
What the public records show
CMS Open Payments records show Mitchell Wicker, MD received $215.05 in general payments during 2025 across 9 reported records.
Axsome Therapeutics, Inc. accounted for 31.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 171 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $68.47 | 31.8% | 2 | 2025 |
| Grifols USA, LLC | Unresolved — no canonical attribution shown | $58.28 | 27.1% | 3 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $51.76 | 24.1% | 2 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $19.06 | 8.9% | 1 | 2025 |
| Gilead Sciences, Inc. | Unresolved — no canonical attribution shown | $17.48 | 8.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $215.05 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $68.47 | 2 | 2025 |
Source payment records
|
|||||
| Prolastin-C Liquid Normalized: prolastin c liquid |
Biological | Grifols USA, LLC | $58.28 | 3 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $51.76 | 2 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $19.06 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
171 | 31 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Pantoprazole Sodium | Pantoprazole Sodium | 726 | 122 |
| Gabapentin | Gabapentin | 718 | 78 |
| Levothyroxine Sodium | Levothyroxine Sodium | 706 | 102 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 700 | 88 |
| Lisinopril | Lisinopril | 699 | 114 |
| Atorvastatin Calcium | Atorvastatin Calcium | 666 | 107 |
| Metoprolol Tartrate | Metoprolol Tartrate | 610 | 95 |
| Potassium Chloride | Potassium Chloride | 473 | 75 |
| Omeprazole | Omeprazole | 448 | 76 |
| Furosemide | Furosemide | 444 | 72 |
| Amlodipine Besylate | Amlodipine Besylate | 440 | 72 |
| Metformin Hcl | Metformin Hcl | 404 | 69 |
| Allopurinol | Allopurinol | 378 | 54 |
| Clopidogrel | Clopidogrel Bisulfate | 337 | 49 |
| Eliquis | Apixaban | 330 | 40 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 320 | 38 |
| Pravastatin Sodium | Pravastatin Sodium | 314 | 49 |
| Trazodone Hcl | Trazodone Hcl | 291 | 36 |
| Tamsulosin Hcl | Tamsulosin Hcl | 287 | 45 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 276 | 44 |
| Glipizide | Glipizide | 267 | 47 |
| Metoprolol Succinate | Metoprolol Succinate | 265 | 47 |
| Hydrochlorothiazide | Hydrochlorothiazide | 250 | 44 |
| Sertraline Hcl | Sertraline Hcl | 238 | 37 |
| Montelukast Sodium | Montelukast Sodium | 226 | 39 |
| Alprazolam | Alprazolam | 218 | 27 |
| Losartan Potassium | Losartan Potassium | 215 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 212 | 42 |
| Simvastatin | Simvastatin | 192 | 33 |
| Hydralazine Hcl | Hydralazine Hcl | 189 | 32 |
| Tramadol Hcl | Tramadol Hcl | 185 | 25 |
| Famotidine | Famotidine | 182 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 181 | 25 |
| Clonidine Hcl | Clonidine Hcl | 175 | 27 |
| Carvedilol | Carvedilol | 171 | 30 |
| Ozempic | Semaglutide | 171 | 31 |
| Buspirone Hcl | Buspirone Hcl | 170 | 22 |
| Chlorthalidone | Chlorthalidone | 169 | 29 |
| Donepezil Hcl | Donepezil Hcl | 169 | 29 |
| Meloxicam | Meloxicam | 169 | 28 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 169 | 30 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 168 | 27 |
| Spironolactone | Spironolactone | 146 | 21 |
| Farxiga | Dapagliflozin Propanediol | 140 | 23 |
| Clonazepam | Clonazepam | 132 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 122 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 121 | 18 |
| Pregabalin | Pregabalin | 119 | 13 |
| Glipizide Er | Glipizide | 115 | 18 |
| Xifaxan | Rifaximin | 115 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 114 | 17 |
| Mirtazapine | Mirtazapine | 109 | 15 |
| Xarelto | Rivaroxaban | 105 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 103 | 11 |
| Atenolol | Atenolol | 99 | 25 |
| Ranolazine Er | Ranolazine | 99 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 98 | 16 |
| Januvia | Sitagliptin Phosphate | 95 | 16 |
| Propranolol Hcl | Propranolol Hcl | 94 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 91 | 19 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 89 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 88 | 71 |
| Fenofibrate | Fenofibrate Nanocrystallized | 88 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 88 | 22 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 85 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 84 | 14 |
| Levetiracetam | Levetiracetam | 84 | suppressed |
| Lorazepam | Lorazepam | 82 | suppressed |
| Prednisone | Prednisone | 81 | 29 |
| Ibuprofen | Ibuprofen | 80 | 23 |
| Warfarin Sodium | Warfarin Sodium | 76 | 11 |
| Ezetimibe | Ezetimibe | 73 | 12 |
| Finasteride | Finasteride | 73 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 72 | 25 |
| Baclofen | Baclofen | 70 | 11 |
| Memantine Hcl | Memantine Hcl | 66 | suppressed |
| Diazepam | Diazepam | 65 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 65 | suppressed |
| Jardiance | Empagliflozin | 64 | suppressed |
| Novolin R | Insulin Regular, Human | 63 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 63 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 60 | 22 |
| Fenofibrate | Fenofibrate | 59 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 57 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 57 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 57 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 56 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 53 | suppressed |
| Topiramate | Topiramate | 53 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 53 | suppressed |
| Cephalexin | Cephalexin | 52 | 45 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 51 | suppressed |
| Nitroglycerin | Nitroglycerin | 51 | 26 |
| Paroxetine Hcl | Paroxetine Hcl | 51 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 49 | suppressed |
| Celecoxib | Celecoxib | 47 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 47 | suppressed |
| Bupropion Xl | Bupropion Hcl | 46 | suppressed |
| Glyburide | Glyburide | 46 | suppressed |
| Roflumilast | Roflumilast | 46 | suppressed |
| Tradjenta | Linagliptin | 46 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 45 | 12 |
| Linzess | Linaclotide | 44 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 44 | suppressed |
| Nabumetone | Nabumetone | 44 | suppressed |
| Aripiprazole | Aripiprazole | 43 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 43 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 43 | 13 |
| Entresto | Sacubitril/Valsartan | 42 | suppressed |
| Sucralfate | Sucralfate | 41 | suppressed |
| Cilostazol | Cilostazol | 40 | suppressed |
| Digoxin | Digoxin | 40 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 39 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 37 | suppressed |
| Phenytoin | Phenytoin | 37 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 37 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 36 | suppressed |
| Azithromycin | Azithromycin | 35 | 29 |
| Oxybutynin Chloride | Oxybutynin Chloride | 35 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Metolazone | Metolazone | 34 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 34 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 33 | suppressed |
| Mounjaro | Tirzepatide | 33 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 32 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 32 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 25 |
| Brilinta | Ticagrelor | 30 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 30 | suppressed |
| Verapamil Er | Verapamil Hcl | 30 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 29 | suppressed |
| Dutasteride | Dutasteride | 29 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 29 | suppressed |
| Nystop | Nystatin | 29 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 29 | suppressed |
| Primidone | Primidone | 29 | suppressed |
| Sotalol | Sotalol Hcl | 29 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 27 | suppressed |
| Olanzapine | Olanzapine | 27 | suppressed |
| Phenobarbital | Phenobarbital | 27 | suppressed |
| Risperidone | Risperidone | 27 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 26 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 26 | suppressed |
| Fentanyl | Fentanyl | 26 | suppressed |
| Fluconazole | Fluconazole | 26 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 26 | 11 |
| Constulose | Lactulose | 25 | suppressed |
| Gemfibrozil | Gemfibrozil | 25 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 24 | suppressed |
| Humalog | Insulin Lispro | 24 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 23 | suppressed |
| Nifedipine Er | Nifedipine | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 22 | suppressed |
| Synthroid | Levothyroxine Sodium | 22 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 20 | suppressed |
| Humulin R | Insulin Regular, Human | 19 | suppressed |
| Lactulose | Lactulose | 19 | 12 |
| Movantik | Naloxegol Oxalate | 19 | suppressed |
| Ramipril | Ramipril | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | 17 |
| Ventolin Hfa | Albuterol Sulfate | 19 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 18 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 18 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 18 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 16 |
| Haloperidol | Haloperidol | 17 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 17 | suppressed |
| Novolog | Insulin Aspart | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 16 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 16 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 15 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 15 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 15 | 12 |
| Latanoprost | Latanoprost | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 15 | suppressed |
| Cholestyramine Light | Cholestyramine | 14 | suppressed |
| Klor-Con M20 | Potassium Chloride | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Prolastin C | Alpha-1-Proteinase Inhibitor | 14 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 14 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Zubsolv | Buprenorphine Hcl/Naloxone Hcl | 14 | suppressed |
| Alogliptin | Alogliptin Benzoate | 13 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 13 | suppressed |
| Levemir Flexpen | Insulin Detemir | 13 | suppressed |
| Nadolol | Nadolol | 13 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 12 | suppressed |
| Desipramine Hcl | Desipramine Hcl | 12 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 11 | suppressed |
| Ibu | Ibuprofen | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $215.05 · 9 records | Axsome Therapeutics, Inc. | Auvelity, Dexcom G6 Transmitter, Prolastin-C Liquid, Wegovy | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error